nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE7B—adipose tissue—polycystic ovary syndrome	0.0158	0.0551	CbGeAlD
Flavoxate—PDE7B—adrenal gland—polycystic ovary syndrome	0.0142	0.0494	CbGeAlD
Flavoxate—PDE8A—adrenal cortex—polycystic ovary syndrome	0.0141	0.0491	CbGeAlD
Flavoxate—PDE7A—endocrine gland—polycystic ovary syndrome	0.014	0.049	CbGeAlD
Flavoxate—PDE8B—uterus—polycystic ovary syndrome	0.0129	0.0449	CbGeAlD
Flavoxate—PDE8B—adipose tissue—polycystic ovary syndrome	0.0126	0.0439	CbGeAlD
Flavoxate—PDE8A—endometrium—polycystic ovary syndrome	0.0125	0.0438	CbGeAlD
Flavoxate—PDE8A—uterus—polycystic ovary syndrome	0.0116	0.0404	CbGeAlD
Flavoxate—PDE8A—pituitary gland—polycystic ovary syndrome	0.0114	0.0396	CbGeAlD
Flavoxate—PDE8A—adipose tissue—polycystic ovary syndrome	0.0113	0.0395	CbGeAlD
Flavoxate—PDE8B—adrenal gland—polycystic ovary syndrome	0.0113	0.0394	CbGeAlD
Flavoxate—PDE8B—vagina—polycystic ovary syndrome	0.0104	0.0365	CbGeAlD
Flavoxate—PDE4D—adipose tissue—polycystic ovary syndrome	0.0102	0.0358	CbGeAlD
Flavoxate—PDE8A—adrenal gland—polycystic ovary syndrome	0.0101	0.0354	CbGeAlD
Flavoxate—PDE8B—endocrine gland—polycystic ovary syndrome	0.00978	0.0341	CbGeAlD
Flavoxate—PDE8A—female gonad—polycystic ovary syndrome	0.00946	0.033	CbGeAlD
Flavoxate—PDE8A—vagina—polycystic ovary syndrome	0.0094	0.0328	CbGeAlD
Flavoxate—PDE4D—adrenal gland—polycystic ovary syndrome	0.00919	0.0321	CbGeAlD
Flavoxate—PDE4A—adipose tissue—polycystic ovary syndrome	0.00907	0.0317	CbGeAlD
Flavoxate—PDE4D—female gonad—polycystic ovary syndrome	0.00857	0.0299	CbGeAlD
Flavoxate—PDE4A—adrenal gland—polycystic ovary syndrome	0.00813	0.0284	CbGeAlD
Flavoxate—PDE4A—female gonad—polycystic ovary syndrome	0.00758	0.0265	CbGeAlD
Flavoxate—PDE4B—endometrium—polycystic ovary syndrome	0.006	0.0209	CbGeAlD
Flavoxate—PDE4B—pituitary gland—polycystic ovary syndrome	0.00543	0.019	CbGeAlD
Flavoxate—PDE4B—adipose tissue—polycystic ovary syndrome	0.00541	0.0189	CbGeAlD
Flavoxate—PDE4B—adrenal gland—polycystic ovary syndrome	0.00485	0.0169	CbGeAlD
Flavoxate—PDE4B—female gonad—polycystic ovary syndrome	0.00452	0.0158	CbGeAlD
Flavoxate—PDE4B—vagina—polycystic ovary syndrome	0.00449	0.0157	CbGeAlD
Flavoxate—PDE4B—endocrine gland—polycystic ovary syndrome	0.00421	0.0147	CbGeAlD
Flavoxate—CHRM2—endocrine gland—polycystic ovary syndrome	0.00418	0.0146	CbGeAlD
Flavoxate—Raloxifene—CYP19A1—polycystic ovary syndrome	0.0041	1	CrCbGaD
Flavoxate—CHRM1—endocrine gland—polycystic ovary syndrome	0.0038	0.0133	CbGeAlD
Flavoxate—PDE7B—Signaling Pathways—POMC—polycystic ovary syndrome	0.000143	0.000202	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000142	0.000201	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—INS—polycystic ovary syndrome	0.000142	0.000201	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000142	0.0002	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000142	0.0002	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000142	0.000199	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000141	0.000199	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000141	0.000198	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000141	0.000198	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00014	0.000197	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00014	0.000197	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00014	0.000197	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000139	0.000197	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000139	0.000196	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000139	0.000196	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000139	0.000196	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000139	0.000196	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000138	0.000195	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000138	0.000195	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000138	0.000195	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000138	0.000195	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000138	0.000194	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000138	0.000194	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000138	0.000194	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000137	0.000193	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000136	0.000192	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000135	0.000191	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000134	0.000189	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000134	0.000189	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000133	0.000188	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000133	0.000187	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000133	0.000187	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—INS—polycystic ovary syndrome	0.000132	0.000186	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000131	0.000185	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000131	0.000185	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000131	0.000185	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000131	0.000184	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00013	0.000183	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00013	0.000183	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000129	0.000182	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000129	0.000182	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000129	0.000181	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000129	0.000181	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000129	0.000181	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000129	0.000181	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000128	0.00018	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000128	0.00018	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000128	0.00018	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PRL—polycystic ovary syndrome	0.000127	0.00018	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000127	0.000178	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000125	0.000176	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000124	0.000175	CbGpPWpGaD
Flavoxate—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000124	0.000174	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000123	0.000173	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000123	0.000173	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000123	0.000173	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000123	0.000173	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000122	0.000173	CbGpPWpGaD
Flavoxate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000122	0.000172	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000122	0.000171	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000122	0.000171	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000121	0.000171	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000121	0.000171	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000121	0.00017	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00012	0.00017	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00012	0.000169	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000119	0.000168	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000119	0.000168	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000118	0.000166	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000118	0.000166	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000118	0.000166	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000117	0.000165	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000116	0.000164	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000115	0.000162	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000115	0.000162	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000113	0.00016	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000113	0.000159	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000113	0.000159	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000112	0.000158	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000112	0.000158	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000112	0.000157	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000108	0.000152	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000107	0.000151	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000107	0.00015	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000106	0.00015	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000106	0.000149	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000105	0.000148	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000105	0.000148	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000104	0.000147	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000103	0.000145	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000103	0.000145	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000102	0.000143	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000102	0.000143	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—LEP—polycystic ovary syndrome	0.000101	0.000142	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000101	0.000142	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000101	0.000142	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NRG1—polycystic ovary syndrome	9.98e-05	0.000141	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GNAS—polycystic ovary syndrome	9.87e-05	0.000139	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—IL6—polycystic ovary syndrome	9.79e-05	0.000138	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	9.62e-05	0.000136	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	9.49e-05	0.000134	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	9.42e-05	0.000133	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.4e-05	0.000133	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	9.35e-05	0.000132	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	9.3e-05	0.000131	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	9.26e-05	0.000131	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	9.23e-05	0.00013	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NRG1—polycystic ovary syndrome	9.23e-05	0.00013	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	9.04e-05	0.000127	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IRS1—polycystic ovary syndrome	9e-05	0.000127	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.99e-05	0.000127	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IRS2—polycystic ovary syndrome	8.98e-05	0.000127	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	8.93e-05	0.000126	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	8.8e-05	0.000124	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—LEP—polycystic ovary syndrome	8.79e-05	0.000124	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	8.68e-05	0.000122	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—POMC—polycystic ovary syndrome	8.67e-05	0.000122	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—INS—polycystic ovary syndrome	8.62e-05	0.000122	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	8.57e-05	0.000121	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IRS2—polycystic ovary syndrome	8.55e-05	0.00012	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	8.52e-05	0.00012	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	8.47e-05	0.000119	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	8.46e-05	0.000119	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	8.41e-05	0.000119	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	8.37e-05	0.000118	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—LEP—polycystic ovary syndrome	8.36e-05	0.000118	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	8.36e-05	0.000118	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.36e-05	0.000118	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IGF1—polycystic ovary syndrome	8.34e-05	0.000118	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AKT2—polycystic ovary syndrome	8.33e-05	0.000117	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	8.26e-05	0.000116	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	8.18e-05	0.000115	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	8.07e-05	0.000114	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	7.92e-05	0.000112	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.92e-05	0.000112	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IRS2—polycystic ovary syndrome	7.91e-05	0.000111	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	7.9e-05	0.000111	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	7.84e-05	0.000111	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IRS1—polycystic ovary syndrome	7.84e-05	0.00011	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	7.82e-05	0.00011	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	7.8e-05	0.00011	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	7.74e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	7.74e-05	0.000109	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—LEP—polycystic ovary syndrome	7.74e-05	0.000109	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	7.66e-05	0.000108	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	7.64e-05	0.000108	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—POMC—polycystic ovary syndrome	7.55e-05	0.000106	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—INS—polycystic ovary syndrome	7.51e-05	0.000106	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	7.48e-05	0.000105	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IRS1—polycystic ovary syndrome	7.46e-05	0.000105	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	7.38e-05	0.000104	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	7.35e-05	0.000104	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	7.29e-05	0.000103	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IGF1—polycystic ovary syndrome	7.26e-05	0.000102	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	7.26e-05	0.000102	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	7.26e-05	0.000102	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AKT2—polycystic ovary syndrome	7.25e-05	0.000102	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	7.2e-05	0.000101	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—POMC—polycystic ovary syndrome	7.18e-05	0.000101	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	7.18e-05	0.000101	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—INS—polycystic ovary syndrome	7.14e-05	0.000101	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	7.09e-05	9.99e-05	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL6—polycystic ovary syndrome	6.98e-05	9.83e-05	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL6—polycystic ovary syndrome	6.98e-05	9.83e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.91e-05	9.74e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.91e-05	9.73e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IRS1—polycystic ovary syndrome	6.9e-05	9.73e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.89e-05	9.72e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	6.81e-05	9.59e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	6.72e-05	9.47e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	6.71e-05	9.46e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—POMC—polycystic ovary syndrome	6.65e-05	9.37e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	6.63e-05	9.34e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—INS—polycystic ovary syndrome	6.61e-05	9.32e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.56e-05	9.25e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	6.42e-05	9.05e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IGF1—polycystic ovary syndrome	6.39e-05	9.01e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AKT2—polycystic ovary syndrome	6.39e-05	9.01e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL6—polycystic ovary syndrome	6.38e-05	8.99e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	6.34e-05	8.93e-05	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL6—polycystic ovary syndrome	6.22e-05	8.77e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.1e-05	8.59e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.07e-05	8.56e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	6.02e-05	8.48e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	6e-05	8.46e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	5.94e-05	8.38e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	5.93e-05	8.35e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	5.87e-05	8.27e-05	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL6—polycystic ovary syndrome	5.78e-05	8.15e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL6—polycystic ovary syndrome	5.55e-05	7.83e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	5.52e-05	7.79e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	5.52e-05	7.79e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	5.45e-05	7.69e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	5.45e-05	7.69e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.45e-05	7.68e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.32e-05	7.5e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL6—polycystic ovary syndrome	5.28e-05	7.45e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	5.27e-05	7.43e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	5.25e-05	7.41e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	5.2e-05	7.33e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.14e-05	7.24e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.12e-05	7.21e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	5.07e-05	7.15e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	5.05e-05	7.12e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6—polycystic ovary syndrome	4.89e-05	6.89e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	4.86e-05	6.86e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	4.83e-05	6.81e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	4.82e-05	6.79e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	4.8e-05	6.77e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	4.77e-05	6.72e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	4.76e-05	6.71e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.74e-05	6.68e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.65e-05	6.55e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	4.59e-05	6.46e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.57e-05	6.45e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.51e-05	6.36e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.51e-05	6.36e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	4.24e-05	5.98e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	4.19e-05	5.9e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.18e-05	5.89e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.04e-05	5.69e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.99e-05	5.62e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	3.96e-05	5.59e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	3.91e-05	5.52e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6—polycystic ovary syndrome	3.77e-05	5.31e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	3.4e-05	4.79e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	3.35e-05	4.73e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	3.32e-05	4.68e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	3.28e-05	4.62e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6—polycystic ovary syndrome	3.28e-05	4.62e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6—polycystic ovary syndrome	3.12e-05	4.4e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.96e-05	4.18e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.93e-05	4.13e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6—polycystic ovary syndrome	2.89e-05	4.07e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	2.85e-05	4.02e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	2.84e-05	4e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	2.82e-05	3.97e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	2.8e-05	3.95e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.75e-05	3.87e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.74e-05	3.87e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.71e-05	3.82e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.71e-05	3.82e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.61e-05	3.68e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.57e-05	3.63e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.1e-05	2.96e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	2.07e-05	2.92e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.79e-05	2.53e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.77e-05	2.5e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	1.24e-05	1.75e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	1.22e-05	1.73e-05	CbGpPWpGaD
